Depletion of PFKP successfully inhibited the growth of brain tumors derived from intracranially injected LN229/EGFRvIII cells at day 18 (Fig. 1A) and prolonged the survival time of the mice (Supplementary Fig. S1B). This evidence concerns the gene PFKP and brain neoplasm.